☆ 4.5 Article

SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin

BIODRUGS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Allergy

Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

Isabelle Meyts et al.

Summary: The study shows that patients with IEI exhibit varied responses to SARS-CoV-2 infection, with some requiring hospitalization and even intensive care, and a non-negligible mortality rate. In comparison to the general population, younger IEI patients may face a higher risk of severe illness and mortality.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency

Samaneh Delavari et al.

Summary: A study on patients with primary immunodeficiency disorders showed that while their incidence of infections was only 1.23 times higher than the general population, their mortality rate was 10 times higher, particularly in patients with combined immunodeficiency and immune dysregulation. Further management strategies such as hematopoietic stem cell transplantation and immunomodulatory agents should be considered to improve the survival rate in these patients.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

R. Libster et al.

Summary: A randomized, double-blind, placebo-controlled trial of convalescent plasma with high IgG titers against SARS-CoV-2 in older adult patients within 72 hours after the onset of mild Covid-19 symptoms found that early administration of high-titer convalescent plasma reduced the progression of Covid-19 in mildly ill infected older adults.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

M. J. Joyner et al.

Summary: This study found that higher anti-SARS-CoV-2 IgG antibody levels in convalescent plasma were associated with a lower risk of death among patients hospitalized with Covid-19 who were not receiving mechanical ventilation. The association between antibody levels and mortality risk was moderated by mechanical ventilation status, with no significant effect seen in patients who had already received ventilation.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

V. A. Simonovich et al.

Summary: There were no significant differences observed in clinical status or overall mortality between patients treated with convalescent plasma and those who received placebo in the treatment of severe Covid-19 pneumonia. The study results indicate that both groups had similar clinical outcomes and mortality rates after 30 days.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Review Medicine, General & Internal

The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis

Stephen A. Klassen et al.

Summary: Studies show that COVID-19 convalescent plasma can lower mortality rates in patients, especially when administered early and with higher antibody titers.

MAYO CLINIC PROCEEDINGS (2021)

添加到收藏夹

Article Hematology

Longitudinal analysis of SARS-CoV-2 antibodies in 8000 US first-time convalescent plasma donations

Michael Karbiener et al.

Summary: Since the onset of the pandemic, the average SARS-CoV-2 IgG values of first-time U.S. COVID-19 convalescent plasma donations have significantly dropped, mainly due to donations from progressively younger aged donors who tend to experience less severe COVID-19.

TRANSFUSION (2021)

添加到收藏夹

Article Virology

SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays

Gregory J. Walker et al.

Summary: Serological testing for SARS-CoV-2-specific antibodies plays a crucial role in understanding COVID-19 prevalence, incidence, and immune response. The study found a strong correlation between neutralising antibodies and certain commercially available EIAs, indicating their potential use in assessing protection post-infection or vaccination, and in screening convalescent plasma donors. The type of antibody and target antigen used in the assays were identified as crucial determinants of assay performance.

VIRUSES-BASEL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers

Stephane Marot et al.

Summary: This study found that SARS-CoV-2 infection can induce neutralizing antibody response correlated with antibody levels, but this neutralizing activity declines after two months post-disease onset, suggesting the need for maintaining infection prevention measures and considering periodic vaccination boosts.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Biology

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19

Daniele Focosi et al.

Summary: Effective treatments specific for COVID-19 are still lacking, but passive immunotherapies based on neutralizing antibodies have shown potential benefits in early disease course. COVID-19 convalescent plasma and monoclonal antibodies have been granted emergency use authorization, while hyperimmune serum derived from CCP donations or animals immunized with SARS-CoV-2 antigens may be the next nAb-derived candidate.

LIFE-BASEL (2021)

添加到收藏夹

Article Immunology

Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma

Shaukat Ali et al.

Summary: This study successfully produced hyperimmune anti-COVID-19 intravenously administrable immunoglobulin (C-IVIG) with high titers of SARS-CoV-2 antibody using simple technology and locally available pooled convalescent plasma. The safety and efficacy of C-IVIG will be evaluated in a registered clinical trial.

IMMUNOTHERAPY (2021)

添加到收藏夹

Article Immunology

Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency

Hannah Kinoshita et al.

Summary: This study characterized antibody and T cell responses to SARS-CoV-2 structural proteins in patients with antibody deficiencies, showing robust T cell activity and humoral immunity in some patients. The study results are encouraging, especially considering the reliance on spike protein in most candidate vaccines, but further research is needed to define the timing of immunity onset, longevity of immune response, and variability in immunocompromised patients.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic

Maria R. Farcet et al.

Summary: The study found that the levels of SARS-CoV-2 neutralizing antibodies in immunoglobulin lots released since March 2020 have been steadily increasing, reaching a high level by January 2021. It is projected that by July 2021, the anti-SARS-CoV-2 potency in immunoglobulins could further enhance.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Medicine, General & Internal

WHO International Standard for anti-SARS-CoV-2 immunoglobulin

Paul A. Kristiansen et al.

LANCET (2021)

添加到收藏夹

Article Multidisciplinary Sciences

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

Leonidas Stamatatos et al.

Summary: The study found that vaccination of both previously infected individuals and those who were not infected resulted in increased neutralizing antibody titers, with previously infected individuals showing a greater boost in neutralizing titers. Vaccination of naive individuals also elicited cross-neutralizing responses, but at lower titers.

SCIENCE (2021)

添加到收藏夹

Article Hematology

Brief report: Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma

Peter Vandeberg et al.

Summary: This study utilized convalescent plasma to manufacture anti-SARS-CoV-2 hyperimmune globulin (hIVIG) with high purity and concentrated antibody activity, potentially serving as an effective treatment for COVID-19.

TRANSFUSION (2021)

添加到收藏夹

Article Hematology

Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors

Molly A. Vickers et al.

Summary: After vaccination, recovered COVID-19 patients showed significant increases in spike-specific and neutralizing antibodies, surpassing levels seen in COVID-19 patients who were not vaccinated. Hence, recovered COVID-19 subjects who are vaccinated may be ideal candidates for CCP donation.

TRANSFUSION (2021)

添加到收藏夹

Article Oncology

Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)

David Tougeron et al.

Summary: The SARS-CoV-2 pandemic has significantly impacted cancer care, creating a high risk of death from COVID-19 in patients undergoing chemotherapy. Vaccination with SARS-CoV-2 vaccines is crucial for reducing severe cases of COVID-19 in cancer patients and restoring normal cancer care. Priority for vaccination should be given to high-risk cancer patients receiving chemotherapy.

EUROPEAN JOURNAL OF CANCER (2021)

添加到收藏夹

Article Medicine, General & Internal

Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities

Myron S. Cohen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021

Jefferson M. Jones et al.

Summary: A study based on blood donations in the US from July 2020 to May 2021 found that seroprevalence of SARS-CoV-2 antibodies induced by vaccination or infection increased over time and varied by age, race and ethnicity, and geographic region. Despite adjustments for demographic differences, the findings may not be fully representative of the entire US population.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Allergy

Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity

David Hagin et al.

Summary: The study evaluated the humoral and cellular immune response to the COVID-19 vaccine in patients with IEI, finding that most patients were able to develop vaccine-specific antibody response and S-protein-specific cellular response, and no significant adverse events were reported during the vaccination process.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

Rita E. Chen et al.

Summary: Cell culture experiments showed reduced or abrogated neutralizing activity of monoclonal antibodies against SARS-CoV-2 variant strains, but low prophylactic doses of antibody combinations protected against infection in vivo without resistance emergence. Higher doses of several monoclonal antibody cocktails also provided protection against viruses with a B.1.351 spike gene in vivo. Many antibody products with Emergency Use Authorization should therefore retain substantial efficacy against prevailing variant strains of SARS-CoV-2.

NATURE (2021)

添加到收藏夹

Article Cell Biology

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States

Heather Kalish et al.

Summary: The study analyzed undiagnosed SARS-CoV-2 infections in the United States and found a high prevalence rate, with different seropositivity estimates among various racial, age, gender, ethnic, and urban/rural groups. Data indicated that as of mid-July 2020, there were an estimated 16.8 million undiagnosed infections in the United States, with 4.8 undiagnosed cases for every diagnosed case of COVID-19.

SCIENCE TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Review Public, Environmental & Occupational Health

Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis

Henry T. Peng et al.

Summary: Convalescent plasma (CP) obtained from recovered COVID-19 patients has shown positive results in various studies for both prophylactic and therapeutic treatment. However, more well-designed randomized controlled trials (RCTs) are needed to establish the clear benefits of CP therapy in patients with COVID-19. Future research is essential to address the gaps in knowledge regarding the prevention and treatment of COVID-19 patients with CP.

JMIR PUBLIC HEALTH AND SURVEILLANCE (2021)

添加到收藏夹

Article Medical Laboratory Technology

Evaluation of 3 SARS-CoV-2 IgG Antibody Assays and Correlation with Neutralizing Antibodies

Jenna Rychert et al.

Summary: The three commonly used SARS-CoV-2 IgG assays showed comparable performance characteristics in clinical sensitivity and specificity, and qualitative IgG positive results were associated with the presence of neutralizing antibodies. However, there was a weak correlation between neutralizing antibody concentrations and signal to cutoff ratios.

JOURNAL OF APPLIED LABORATORY MEDICINE (2021)

添加到收藏夹

Article Cell Biology

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases

Alison Tarke et al.

Summary: By studying T cell responses in 99 convalescent COVID-19 cases, we identified various HLA-restricted epitopes derived from SARS-CoV-2 and observed distinct patterns of immunodominance. The epitopes were combined into megapools to facilitate the identification and quantification of virus-specific CD4(+) and CD8(+) T cells.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Editorial Material Infectious Diseases

Convalescent plasma as a potential therapy for COVID-19

Long Chen et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Virology

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

A. J. Jaaskelainen et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Davide F. Robbiani et al.

NATURE (2020)

添加到收藏夹

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Hematology

Characteristics and serological patterns ofCOVID-19 convalescent plasma donors: optimal donors and timing of donation

Ling Li et al.

TRANSFUSION (2020)

添加到收藏夹

Review Hematology

Treatment for emerging viruses: Convalescent plasma and COVID-19

Bethany L. Brown et al.

TRANSFUSION AND APHERESIS SCIENCE (2020)

添加到收藏夹

Article Immunology

Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins

Jose Maria Diez et al.

IMMUNOTHERAPY (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study

Isaac R. Melamed et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)

添加到收藏夹

Article Oncology

Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid

Kai Uwe Radomski et al.

BIODRUGS (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials

Wolfgang Frenzel et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2016)

添加到收藏夹

Article Infectious Diseases

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study

Marcel A. Mueller et al.

LANCET INFECTIOUS DISEASES (2015)

添加到收藏夹

Review Immunology

Primary antibody deficiencies

Anne Durandy et al.

NATURE REVIEWS IMMUNOLOGY (2013)

添加到收藏夹

Article Immunology

An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system

Klaus K. Orlinger et al.

VACCINE (2010)

添加到收藏夹

Article Statistics & Probability

Fast Implementation for Normal Mixed Effects Models With Censored Response

Florin Vaida et al.

JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS (2009)

添加到收藏夹

Article Allergy

Pharmacokinetics of Immunoglobulin Administered via Intravenous or Subcutaneous Routes

Francisco A. Bonilla

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.